Literature DB >> 24673330

Paracetamol induced Stevens-Johnson syndrome--toxic epidermal necrolysis overlap syndrome.

Sasmita Biswal1, Swayam Sourav Sahoo.   

Abstract

BACKGROUND: Though any drug can be a potential cause of such hypersensitivity reactions, paracetamol, an over-the-counter drug used extensively as an analgesic and antipyretic agent, is considered to be relatively safe, with hepatotoxicity as a major adverse effect only in large doses.
MATERIALS AND METHODS: We report an instance of a severe case of SJS-TEN overlap syndrome in a 12-year-old girl, induced by three over-the-counter doses of 500 mg of paracetamol taken at 8-hour intervals for fever. RESULTS AND DISCUSSION: Stevens-Johnson Syndrome and its severe variant toxic epidermal necrolysis (TEN) are idiosyncratic, delayed hypersensitivity inflammatory adverse drug reactions that are associated with increased morbidity and mortality. However, treatment with antibiotics and intravenous corticosteroids along with supportive therapy improved the course of the disorder.
CONCLUSION: This case report addresses the fact that severe hypersensitivity reactions can occur with paracetamol, which can be potentially dangerous and life threatening. It is hence important for the clinicians to be alert to such severe hypersensitivity reactions even with drugs which are considered to be potentially safe such as paracetamol.
© 2013 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24673330     DOI: 10.1111/ijd.12355

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Stevens-Johnson syndrome in a patient with rheumatoid arthritis during long-term etanercept therapy.

Authors:  Agnieszka Owczarczyk-Saczonek; Natalia Zdanowska; Aleksandra Znajewska-Pander; Waldemar Placek
Journal:  J Dermatol Case Rep       Date:  2016-03-31

2.  Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.

Authors:  Bénédicte Lebrun-Vignes; Claire Guy; Marie-Josèphe Jean-Pastor; Valérie Gras-Champel; Marie Zenut
Journal:  Br J Clin Pharmacol       Date:  2017-11-10       Impact factor: 4.335

Review 3.  Stevens - Johnson Syndrome and Toxic Epidermal Necrolysis; Extensive Review of Reports of Drug-Induced Etiologies, and Possible Therapeutic Modalities.

Authors:  Adegbenro Omotuyi John Fakoya; Princess Omenyi; Precious Anthony; Favour Anthony; Precious Etti; David Adeiza Otohinoyi; Esther Olunu
Journal:  Open Access Maced J Med Sci       Date:  2018-03-28

4.  Amniotic membrane transplantation in a 2-month-old infant with toxic epidermal necrolysis.

Authors:  Abdelrahman M Elhusseiny; Ryan Gise; Christina Scelfo; Iason S Mantagos
Journal:  Am J Ophthalmol Case Rep       Date:  2021-01-15

5.  Development and Validation of a Questionnaire on Knowledge, Attitude, and Perception Towards Allergic Reactions of Paracetamol.

Authors:  Nur Amalina Dellemin; Zalina Zahari; Mohamed Azmi Ahmad Hassali; Shaharuddin Abdul Rashid
Journal:  J Pharm Bioallied Sci       Date:  2020-10-08

6.  Paracetamol induced Steven-Johnson syndrome: A rare case report.

Authors:  Rajan Rajput; Shitalkumar Sagari; Astha Durgavanshi; Alpana Kanwar
Journal:  Contemp Clin Dent       Date:  2015-09

7.  Survey of Nonprescription Medication and Antibiotic Use in Patients with Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Overlap Syndrome.

Authors:  Katherine J Sullivan; Meghan N Jeffres; Robert P Dellavalle; Robert Valuck; Heather D Anderson
Journal:  Antibiotics (Basel)       Date:  2018-02-01

8.  The psychological impact of Stevens-Johnson syndrome and toxic epidermal necrolysis on patients' lives: a Critically Appraised Topic.

Authors:  P O'Reilly; C Kennedy; P Meskell; A Coffey; I Delaunois; L Dore; S Howard; B Ramsay; C Scanlon; D M Wilson; B Whelan; S Ryan
Journal:  Br J Dermatol       Date:  2020-01-11       Impact factor: 9.302

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.